Pasar al contenido principal

ANTIOXIDANT COMPOUNDS IN INFLAMMATION-RELATED METABOLIC HUMAN DISEASES: IN VITRO AND IN VIVO PHARMACOLOGICAL APPROACHES

RYC-2013-13186

•
Nombre agencia financiadora Ministerio de Ciencia e Innovación
Acrónimo agencia financiadora MICINN
Programa Programa Estatal de Promoción del Talento y su Empleabilidad en I+D+i
Subprograma Subprograma Estatal de Incorporación
Convocatoria Ramón y Cajal
Año convocatoria 2013
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Unidad de gestión Secretaría de Estado de Educación, Formación Profesional y Universidades
Centro beneficiario FUNDACIO INSTITUT D'INVESTIGACIO SANITARIA PERE VIRGILI
Identificador persistente http://dx.doi.org/10.13039/501100004837

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

SUCNR1 controls an anti-inflammatory program in macrophages to regulate the metabolic response to obesity

  • Keiran, Noelia
  • Ceperuelo-Mallafré, Victoria
  • Calvo, Enrique
  • Hernández-Alvarez, Maria Isabel
  • Ejarque, Miriam
  • Núñez-Roa, Catalina
  • Horrillo, Daniel
  • Maymó-Masip, Elsa
  • Rodríguez, M. Mar
  • Fradera, Rosa
  • Rosa, Juan V. de la
  • Jorba, Rosa
  • Megía, Ana
  • Zorzano, Antonio
  • Medina, Gema
  • Serena, Carolina
  • Castrillo, Antonio
  • Vendrell, Joan
  • Fernández-Veledo, Sonia
Succinate is a signaling metabolite sensed extracellularly by succinate receptor 1 (SUNCR1). The accumulation of succinate in macrophages is known to activate a pro-inflammatory program; however, the contribution of SUCNR1 to macrophage phenotype and function has remained unclear. Here we found that activation of SUCNR1 had a critical role in the anti-inflammatory responses in macrophages. Myeloid-specific deficiency in SUCNR1 promoted a local pro-inflammatory phenotype, disrupted glucose homeostasis in mice fed a normal chow diet, exacerbated the metabolic consequences of diet-induced obesity and impaired adipose-tissue browning in response to cold exposure. Activation of SUCNR1 promoted an anti-inflammatory phenotype in macrophages and boosted the response of these cells to type 2 cytokines, including interleukin-4. Succinate decreased the expression of inflammatory markers in adipose tissue from lean human subjects but not that from obese subjects, who had lower expression of SUCNR1 in adipose-tissue-resident macrophages. Our findings highlight the importance of succinate-SUCNR1 signaling in determining macrophage polarization and assign a role to succinate in limiting inflammation., This study was supported by grants from the Spanish Ministry of Science, Innovation and Universities (PI14/00228 and PI17/01503 to J.V., SAF2015-65019-R to S.F.-V., SAF2014-56819-R and SAF2015-71878-REDT to A.C., BFU2016-78951-R to G.M.-M., PI15/00143 to C.S. and PI15/01562 to A.M., BFU2015-70454-REDT and BFU2017-90578-REDT to S.F.-V. and G.M.-M.) co-financed by the European Regional Development Fund (ERDF). The Spanish Biomedical Research Center in Diabetes and Associated Metabolic Disorders (CIBERDEM) (CB07708/0012) is an initiative of the Instituto de Salud Carlos III. N.K. is recipient of a predoctoral fellowship from MINECO, Spain (FPI, BES-2016-077745). C.S. acknowledges support from the ‘Ramón y Cajal’ program from MINECO (RYC2013-13186) and S.F.-V. the Miguel Servet tenure-track program (CP10/00438 and CPII16/00008) from the Fondo de Investigación Sanitaria, co-financed by the ERDF., Peer reviewed
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Adipose stem cells from patients with Crohn's disease show a distinctive DNA methylation pattern

  • Serena, Carolina|||0000-0003-2251-0856
  • Millán Scheiding, Mónica
  • Ejarque, Miriam|||0000-0003-0545-9817
  • Saera-Vila, Alfonso
  • Maymó-Masip, Elsa
  • Núñez Roa, Catalina
  • Monfort-Ferré, Diandra|||0000-0003-3832-4249
  • Terrón-Puig, Margarida
  • Bautista, Michelle
  • Menacho, Margarita
  • Marti-Gallostra, Marc|||0000-0002-0783-6359
  • Espin-Basany, Eloy|||0000-0002-9139-4548
  • Vendrell, Joan|||0000-0002-6994-6115
  • Fernández-Veledo, Sonia|||0000-0003-2906-3788
Crohn's disease (CD) is characterized by persistent inflammation and ulceration of the small or large bowel, and expansion of mesenteric adipose tissue, termed creeping fat (CF). We previously demonstrated that human adipose-derived stem cells (hASCs) from CF of patients with CD exhibit dysfunctional phenotypes, including a pro-inflammatory profile, high phagocytic capacity, and weak immunosuppressive properties. Importantly, these phenotypes persist in patients in remission and are found in all adipose depots explored including subcutaneous fat. We hypothesized that changes in hASCs are a consequence of epigenetic modifications. We applied epigenome-wide profiling with a methylation array (Illumina EPIC/850k array) and gene expression analysis to explore the impact of CD on the methylation signature of hASCs isolated from the subcutaneous fat of patients with CD and healthy controls (n = 7 and 5, respectively; cohort I). Differentially methylated positions (p value cutoff < 1 × 10 -4 and ten or more DMPs per gene) and regions (inclusion threshold 0.2, p value cutoff < 1 × 10 -2 and more than 2 DMRs per gene) were identified using dmpfinder and Bumphunter (minfi), respectively. Changes in the expression of differentially methylated genes in hASCs were validated in a second cohort (n = 10/10 inactive and active CD and 10 controls; including patients from cohort I) and also in peripheral blood mononuclear cells (PBMCs) of patients with active/inactive CD and of healthy controls (cohort III; n = 30 independent subjects). We found a distinct DNA methylation landscape in hASCs from patients with CD, leading to changes in the expression of differentially methylated genes involved in immune response, metabolic, cell differentiation, and development processes. Notably, the expression of several of these genes in hASCs and PBMCs such as tumor necrosis factor alpha (TNFA) and PR domain zinc finger protein 16 (PRDM16) were not restored to normal (healthy) levels after disease remission. hASCs of patients with CD exhibit a unique DNA methylation and gene expression profile, but the expression of several genes are only partially restored in patients with inactive CD, both in hASCs and PBMCs. Understanding how CD shapes the functionality of hASCs is critical for investigating the complex pathophysiology of this disease, as well as for the success of cell-based therapies. Human adipose-stem cells isolated from subcutaneous fat of patients with Crohn's disease exhibit an altered DNA methylation pattern and gene expression profile compared with those isolated from healthy individuals, with immune system, cell differentiation, metabolic and development processes identified as the main pathways affected. Interestingly, the gene expression of several genes involved in these pathways is only partially restored to control levels in patients with inactive Crohn's disease, both in human adipose-stem cells and peripheral blood mononuclear cells. Understanding how Crohn's disease shapes the functionality of human adipose-stem cells is critical for investigating the complex pathophysiology of this disease, as well as for the success of cell-based therapies.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Microbial Signature in Adipose Tissue of Crohn's Disease Patients

  • Serena, Carolina|||0000-0003-2251-0856
  • Queipo-Ortuño, Maribel|||0000-0002-2867-0845
  • Millán Scheiding, Mónica
  • Sanchez-Alcoholado, Lidia
  • Caro, Aleidis|||0000-0001-6151-3879
  • Espina Perez, Beatriz|||0000-0003-1697-9973
  • Menacho, Margarita
  • Bautista, Michelle
  • Monfort-Ferré, Diandra|||0000-0003-3832-4249
  • Terrón-Puig, Margarida
  • Núñez Roa, Catalina
  • Maymó-Masip, Elsa
  • Rodriguez, M. Mar
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Espin-Basany, Eloy|||0000-0002-9139-4548
  • Marti-Gallostra, Marc|||0000-0002-0783-6359
  • Fernández-Veledo, Sonia|||0000-0003-2906-3788
  • Vendrell, Joan|||0000-0002-6994-6115
Crohn's disease (CD) is characterized by compromised immune tolerance to the intestinal commensal microbiota, intestinal barrier inflammation, and hyperplasia of creeping fat (CF) and mesenteric adipose tissue (AT), which seems to be directly related to disease activity. Gut microbiota dysbiosis might be a determining factor in CD etiology, manifesting as a low microbial diversity and a high abundance of potentially pathogenic bacteria. We tested the hypothesis that CF is a reservoir of bacteria through 16S-rRNA sequencing of several AT depots of patients with active and inactive disease and controls. We found a microbiome signature within CF and mesenteric AT from patients, but not in subcutaneous fat. We failed to detect bacterial DNA in any fat depot of controls. Proteobacteria was the most abundant phylum in both CF and mesenteric AT, and positively correlated with fecal calprotectin/C-reactive protein. Notably, the clinical status of patients seemed to be related to the microbiome signature, as those with the inactive disease showed a reduction in the abundance of pathogenic bacteria. Predictive functional profiling revealed many metabolic pathways including lipopolysaccharide biosynthesis and sulfur metabolism overrepresented in active CD relative to that in inactive CD. Our findings demonstrate that microbiota dysbiosis associated with CD pathophysiology is reflected in AT and might contribute to disease severity.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Anti-TNF Therapies Suppress Adipose Tissue Inflammation in Crohn's Disease

  • Boronat-Toscano, Albert|||0000-0003-2650-156X
  • Monfort-Ferré, Diandra|||0000-0003-3832-4249
  • Menacho, Margarita
  • Caro, Aleidis|||0000-0001-6151-3879
  • Bosch Príncep, Ramon|||0000-0003-4104-5515
  • Espina Perez, Beatriz|||0000-0003-1697-9973
  • Algaba, Ferran|||0000-0002-0071-4164
  • Saera-Vila, Alfonso
  • Moliné, Alicia
  • Marti-Gallostra, Marc|||0000-0002-0783-6359
  • Espin-Basany, Eloy|||0000-0002-9139-4548
  • Millán Scheiding, Mónica
  • Serena, Carolina|||0000-0003-2251-0856
Anti-TNF biologics have been shown to markedly improve the quality of life for patients with Crohn's disease (CD), yet one-third of patients fail to benefit from this treatment. Patients with CD develop a characteristic wrapping of visceral adipose tissue (VAT) in the inflamed intestinal area, termed creeping fat, and it is known that adipose tissue expansion influences the efficacy of anti-TNF drugs. We questioned whether anti-TNF therapies impact the creeping fat in CD, which might affect the outcome of the disease. Adipose tissue biopsies were obtained from a cohort of 14 patients with CD that received anti-TNF drugs and from 29 non-anti-TNF-treated patients (control group) matched by sex, age, and body mass index undergoing surgical interventions for symptomatic complications. We found that anti-TNF therapies restored adipose tissue morphology and suppressed immune cell infiltration in the creeping fat. Additionally, anti-TNF treatments appeared to markedly improve the pro-inflammatory phenotype of adipose-tissue macrophages and adipose-tissue-derived stem cells. Our study provides evidence that anti-TNF medications influence immune cells and progenitor cells in the creeping of patients with CD, suppressing inflammation. We propose that perilesional VAT should be considered when administering anti-TNF therapy in patients with CD.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Smoking Suppresses the Therapeutic Potential of Adipose Stem Cells in Crohn's Disease Patients through Epigenetic Changes

  • Boronat-Toscano, Albert|||0000-0003-2650-156X
  • Vañó, Irene
  • Monfort-Ferré, Diandra|||0000-0003-3832-4249
  • Menacho, Margarita
  • Valldosera, Gemma
  • Caro, Aleidis|||0000-0001-6151-3879
  • Espina Perez, Beatriz|||0000-0003-1697-9973
  • Mañas, Maria José|||0000-0002-6580-0784
  • Marti-Gallostra, Marc|||0000-0002-0783-6359
  • Espin-Basany, Eloy|||0000-0002-9139-4548
  • Saera-Vila, Alfonso
  • Serena, Carolina|||0000-0003-2251-0856
Patients with Crohn's disease (CD) who smoke are known to have a worse prognosis than never-smokers and a higher risk for post-surgical recurrence, whereas patients who quit smoking after surgery have significantly lower post-operative recurrence. The hypothesis was that smoking induces epigenetic changes that impair the capacity of adipose stem cells (ASCs) to suppress the immune system. It was also questioned whether this impairment remains in ex-smokers with CD. ASCs were isolated from non-smokers, smokers and ex-smokers with CD and their interactions with immune cells were studied. The ASCs from both smokers and ex-smokers promoted macrophage polarization to an M1 pro-inflammatory phenotype, were not able to inhibit T- and B-cell proliferation in vitro and enhanced the gene and protein expression of inflammatory markers including interleukin-1b. Genome-wide epigenetic analysis using two different bioinformatic approaches revealed significant changes in the methylation patterns of genes that are critical for wound healing, immune and metabolic response and p53-mediated DNA damage response in ASCs from smokers and ex-smokers with CD. In conclusion, cigarette smoking induces a pro-inflammatory epigenetic signature in ASCs that likely compromises their therapeutic potential.